Dear Kelyniam Shareholders, After a record sales year in 2018, revenue from sales of our PEEK implants slowed somewhat in the first half of the year, decreasing 17% to $931,894 from $1,118,512 over the same period in the previous year. Unit volume was down 15% due to lost volume from one of our top distributors....Read More
Text Widget
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada magna mollis euismod.
Recent Comments